Research and Publication Ethics
1. Human Rights and Protection
1) IRB regulation: CHNR endorses and follows international standards of ethical practice in human rights and protection and the principles addressed in the Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects, https://www.wma.net/wp-content/uploads/2016/11/DoH-Oct2013-JAMA.pdf). According to the Bioethics and Biosafety Act of Korea and in order to meet international standards for ethical practice in human rights and protection, any research involving human subjects must be approved by an Institutional Review Board (IRB). The researcher(s) must also obtain written voluntary informed consent from the participants or their parent or legal guardian. If the research involves a child or any vulnerable subject in any way, special and sensitive protection is needed to ensure the safety and human rights of the subject. When necessary, the editor of CHNR may ask the author(s) to present the relevant document(s) on the human rights and protection issues related to the manuscript, such as the informed consent form or the evidence for the IRB approval of the study.
2) When animals are used as research subjects, the study must be conducted in correspondence with related regulations such as those of the Institutional Animal Care and Use Committees (IACUCs), or National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals. Any treatment methods in conflict with the regulations must be described and may be grounds for rejection of the paper.
The research and publication ethics of CHNR strictly follow the International Committee of Medical Journal Editors (ICMJE) guidelines (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html), which state that authorship credit should be based on all of the following: substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND drafting the work or revising it critically for important intellectual content; AND final approval of the version to be published; AND agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All other contributors should be credited in the acknowledgments.
3. Submission Declaration
Duplicate publication or duplicate submission is prohibited. Manuscripts that have been published or are being submitted to other journal(s) should not be submitted to CHNR. Manuscripts that have been published or are currently under consideration for publication in CHNR must not be submitted to another journal. Upon notice of a duplicate submission, submission privileges to CHNR will be suspended for 2 years.
1) Decision criteria for duplicate publication: The manuscript has never been published in another language, or in any medium—print, electronic media, or an academic journal.
2) The corresponding author must obtain approval from the editor-in-chief of each of the related journals if s/he wishes to reprint the published manuscript in another language.
3) The editorial board will determine the nature and degree of duplicate publication or duplicate submission of the manuscript.
1) After the acceptance of the manuscript, the author must submit the copyright transfer agreement to the Korean Academy of Child Health Nursing. All authors should print their names and sign the copyright transfer agreement.
2) All manuscripts published in Child Health Nursing Research are protected by copyright. The copyright and the transfer right of the digital content of the published paper and journal are owned by the Korean Academy of Child Health Nursing. All authors should agree to the copyright transfer during the submission process.
5. Publication Ethics and Malpractice Statements
The publication and research ethics of CHNR strictly follow the ICMJE guidelines (http://www.icmje.org/).
1) Reporting standards: Authors should report on their work accurately and objectively without inappropriate manipulation. Authors should describe their methods and procedures in enough detail and present sufficient references so that others can replicate the work. Authors should not produce, record, or report non-existent data and results, and should not change or omit data. Authors should also avoid producing multiple publications (“salami slicing”) from content that should be only one substantial manuscript. Manuscripts that do not follow the international ethical standards of research and publication (i.e., those that involve fabrication, falsification, salami slicing, plagiarism, or simultaneous/duplicate submission) will not be considered for publication in CHNR. The editorial board will adjudicate the specific reasons for rejection.
2) Authorship of the manuscript: Authorship must be limited to those who have made a substantial contribution to the manuscript in terms of the conception and design, as well as the collection, analysis, and interpretation of the data. All authors should be involved in drafting and revising the manuscript, and must approve the final version of the manuscript. The corresponding author should confirm that all appropriate persons are listed as authors in the manuscript, and all co-authors should approve the final version to be published.
3) Originality and plagiarism: Authors are required to submit original manuscripts, and confirm that they have cited or quoted others’ ideas and texts appropriately and accurately. Plagiarism means the appropriation of another person’s ideas, research processes, results, or text as one’s own. This includes using previously published material of oneself or any other author without citing the reference. The editorial board of CHNR uses the CrossCheck tool to check for plagiarism. If plagiarism is discovered in the manuscript, the manuscript will not be published.
4) Multiple, simultaneous, or duplicate submission: Authors should not submit the same research to more than one journal and should not publish the manuscript in different languages. If authors wish to pursue a secondary publication of the manuscript in another language, they should obtain approval from the editor-in-chief of both related journals. The editorial board will determine the nature and degree of duplicate publication or duplicate submission for the manuscript.
5) Data access and retention: Authors should retain research data and be prepared to allow access to the data in case the editorial board asks them to provide the raw data in connection with editorial review.
6) Disclosure and conflict of interest: Authors are required to disclose commercial or similar relationships to products or companies mentioned in the article being submitted or related to its subject matter.
7) Acknowledgment of sources: Sources of funding for the manuscript should be acknowledged. Authors should use or report the information obtained privately with explicit, written permission from sources.
8) Fundamental errors in a manuscript: When authors find a fundamental error in a published manuscript, they should immediately inform the editor and cooperate with the editor to correct or withdraw the manuscript.
9) Process for managing publication malpractice: When reviewers or readers suspect publication malpractice such as fabrication, falsification, salami slicing, plagiarism, or simultaneous/duplicate publication, the process of resolution will be initiated following the flowchart provided by the Committee on Publication Ethics (COPE). (http://publicationethics.org/resources/flowcharts). The editorial board will discuss and adjudicate the suspected publication malpractice, as well as complaints and appeals against editors.